Hepatitis C virus lacking the hypervariable region 1 of the second envelope protein is infectious and causes acute resolving or persistent infection in chimpanzees.

Persistent infection with hepatitis C virus (HCV) is among the leading causes of chronic liver disease. Previous studies suggested that genetic variation in hypervariable region 1 (HVR1) of the second envelope protein, possibly in response to host immune pressure, influences the outcome of HCV infection. In the present study, a chimpanzee transfected intrahepatically with RNA transcripts of an infectious HCV clone (pCV-H77C) from which HVR1 was deleted became infected; the DeltaHVR1 virus was subsequently transmitted to a second chimpanzee. Infection with DeltaHVR1 virus resulted in persistent infection in the former chimpanzee and in acute resolving infection in the latter chimpanzee. Both chimpanzees developed hepatitis. The DeltaHVR1 virus initially replicated to low titers, but virus titer increased significantly after mutations appeared in the viral genome. Thus, wild-type HCV without HVR1 was apparently attenuated, suggesting a functional role of HVR1. However, our data indicate that HVR1 is not essential for the viability of HCV, the resolution of infection, or the progression to chronicity.

[1]  S. Emerson,et al.  Vaccination of Chimpanzees With Plasmid DNA Encoding the Hepatitis C Virus (HCV) Envelope E2 Protein Modified the Infection After Challenge With Homologous Monoclonal HCV , 2000, Hepatology.

[2]  J. Bukh,et al.  Characterization of modified hepatitis C virus E2 proteins expressed on the cell surface. , 2000, Virology.

[3]  M. Cucchiarini,et al.  Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C. , 2000, The Journal of infectious diseases.

[4]  B. Walker,et al.  Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus , 2000, The Journal of experimental medicine.

[5]  H J Alter,et al.  The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. , 2000, Science.

[6]  J. Jansson,et al.  Growth hormone induces CCAAT/enhancer binding protein α (C/EBPα) in cultured rat hepatocytes , 2000 .

[7]  C. Rice,et al.  Hepatitis C Virus-Encoded Enzymatic Activities and Conserved RNA Elements in the 3′ Nontranslated Region Are Essential for Virus Replication In Vivo , 2000, Journal of Virology.

[8]  R. Purcell,et al.  Quasispecies in viral persistence and pathogenesis of hepatitis C virus. , 1999, Trends in microbiology.

[9]  R H Purcell,et al.  Hepatitis C virus: an infectious molecular clone of a second major genotype (2a) and lack of viability of intertypic 1a and 2a chimeras. , 1999, Virology.

[10]  J. Dubuisson,et al.  Characterization of Hepatitis C Virus E2 Glycoprotein Interaction with a Putative Cellular Receptor, CD81 , 1999, Journal of Virology.

[11]  A. Nicosia,et al.  Hypervariable region 1 variants act as TCR antagonists for hepatitis C virus-specific CD4+ T cells. , 1999, Journal of immunology.

[12]  M. Shapiro,et al.  Viral clearance without destruction of infected cells during acute HBV infection. , 1999, Science.

[13]  P Parham,et al.  Analysis of a successful immune response against hepatitis C virus. , 1999, Immunity.

[14]  O. Laeyendecker,et al.  Acute Hepatitis C Virus Structural Gene Sequences as Predictors of Persistent Viremia: Hypervariable Region 1 as a Decoy , 1999, Journal of Virology.

[15]  M. Yanagi,et al.  In vivo analysis of the 3' untranslated region of the hepatitis C virus after in vitro mutagenesis of an infectious cDNA clone. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[16]  M. Houghton,et al.  Binding of hepatitis C virus to CD81. , 1998, Science.

[17]  Y. Liaw,et al.  Hepatitis C virus variants circumventing cytotoxic T lymphocyte activity as a mechanism of chronicity. , 1998, Gastroenterology.

[18]  J. Bukh,et al.  Experimental infection of chimpanzees with hepatitis C virus of genotype 5a: genetic analysis of the virus and generation of a standardized challenge pool. , 1998, The Journal of infectious diseases.

[19]  Anna Tramontano,et al.  Towards a solution for hepatitis C virus hypervariability: mimotopes of the hypervariable region 1 can induce antibodies cross‐reacting with a large number of viral variants , 1998, The EMBO journal.

[20]  Jane McAllister,et al.  Long-Term Evolution of the Hypervariable Region of Hepatitis C Virus in a Common-Source-Infected Cohort , 1998, Journal of Virology.

[21]  M. Yanagi,et al.  Transcripts of a chimeric cDNA clone of hepatitis C virus genotype 1b are infectious in vivo. , 1998, Virology.

[22]  A. Sette,et al.  Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus. , 1997, The Journal of clinical investigation.

[23]  M. Yanagi,et al.  Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[24]  C. Rice,et al.  Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA. , 1997, Science.

[25]  H. Yagita,et al.  Impaired induction of cytotoxic T lymphocytes by antagonism of a weak agonist borne by a variant hepatitis C virus epitope , 1997, European journal of immunology.

[26]  A. Zibert,et al.  Epitope mapping of antibodies directed against hypervariable region 1 in acute self-limiting and chronic infections due to hepatitis C virus , 1997, Journal of virology.

[27]  A. Zibert,et al.  Early antibody response against hypervariable region 1 is associated with acute self‐limiting infections of hepatitis C virus , 1997, Hepatology.

[28]  S. Jacobson,et al.  Patients infected with the same hepatitis C virus strain display different kinetics of the isolate-specific antibody response. , 1997, The Journal of infectious diseases.

[29]  E. E. Kritzinger,et al.  Medical cardiovascular treatment trials: Relevant to medical ophthalmology in 1997? , 1997, Eye.

[30]  M. Shapiro,et al.  Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[31]  R. Purcell,et al.  A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures. , 1996, Virology.

[32]  M. Massari,et al.  Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. , 1996, The Journal of clinical investigation.

[33]  M. Houghton,et al.  A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[34]  T. Santantonio,et al.  Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection , 1995, The Lancet.

[35]  E. Schreier,et al.  Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment. , 1995, Virology.

[36]  F. Chisari,et al.  Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif. , 1995, The Journal of clinical investigation.

[37]  R. Purcell,et al.  Genetic Heterogeneity of Hepatitis C Virus: Quasispecies and Genotypes , 1995, Seminars in liver disease.

[38]  M. Houghton,et al.  Hepatitis C virus-specific CTL responses in the liver of chimpanzees with acute and chronic hepatitis C. , 1993, Journal of immunology.

[39]  J. Sodroski,et al.  Functional and immunologic characterization of human immunodeficiency virus type 1 envelope glycoproteins containing deletions of the major variable regions , 1993, Journal of virology.

[40]  M. Sakamoto,et al.  A structurally flexible and antigenically variable N-terminal domain of the hepatitis C virus E2/NS1 protein: implication for an escape from antibody. , 1993, Virology.

[41]  N. Kato,et al.  Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus , 1993, Journal of virology.

[42]  Giorgio,et al.  Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[43]  R. Purcell,et al.  Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[44]  N. Kato,et al.  Hypervariable regions in the putative glycoprotein of hepatitis C virus. , 1991, Biochemical and biophysical research communications.

[45]  Matthew J. Brauer,et al.  Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins. , 1991, Virology.